OUL35 [Ligand Id: 13119] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL1438938 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Mono [ADP-ribose] polymerase PARP16 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4105981] [UniProtKB: Q8N5Y8] | ||||||||
| ChEMBL | Inhibition of N-terminal His-tagged human ARTD15 (1 to 280 residues) expressed in Escherichia coli Rosetta2 (DE3) after 24 hrs in presence of NAD+ | B | 5.38 | pIC50 | 4200 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| poly(ADP-ribose) polymerase 1/Poly [ADP-ribose] polymerase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3105] [GtoPdb: 2771] [UniProtKB: P09874] | ||||||||
| ChEMBL | Inhibition of full length recombinant His6-tagged human PARP1 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP1 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of N-terminal His-tagged human ARTD1 (1 to 1014 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+ | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| poly(ADP-ribose) polymerase family member 10/Poly [ADP-ribose] polymerase 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2429708] [GtoPdb: 3267] [UniProtKB: Q53GL7] | ||||||||
| ChEMBL | Inhibition of ARTD10 (unknown origin)-induced cell death expressed in human HeLa cells after 10 days by methylene blue staining based colony formation assay | B | 5.87 | pIC50 | 1350 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| ChEMBL | Inhibition of human PARP10 catalytic domain assessed as reduction in MARylation of His6-tagged SRPK2 substrate after 60 mins in presence of NAD+ by chemifluorescence assay | B | 5.88 | pIC50 | 1318.26 | nM | IC50 | ACS Med Chem Lett (2019) 10: 74-79 [PMID:30655950] |
| ChEMBL | Inhibition of human PARP10 catalytic domain assessed as reduction in MARylation of His6-tagged SRPK2 substrate after 60 mins in presence of NAD+ by chemifluorescence assay | B | 5.89 | pIC50 | 1300 | nM | IC50 | ACS Med Chem Lett (2019) 10: 74-79 [PMID:30655950] |
| ChEMBL | Inhibition of full length recombinant His6-tagged human PARP10 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.19 | pIC50 | 645.65 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of full length recombinant His6-tagged human PARP10 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of C-terminal His-tagged human ARTD10 (809 to 1017 residues) R931A mutant expressed in Escherichia coli Rosetta2 (DE3) Rosetta2 (DE3) using SRPK2 as substrate after 21 hrs in presence of NAD+ | B | 6.22 | pIC50 | 600 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| GtoPdb | - | - | 6.48 | pIC50 | 330 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| ChEMBL | Inhibition of C-terminal His-tagged human ARTD10 (809 to 1017 residues) expressed in Escherichia coli Rosetta2 (DE3) using SRPK2 as substrate after 13 hrs in presence of NAD+ | B | 6.48 | pIC50 | 330 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP10 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 6.48 | pIC50 | 329 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| poly(ADP-ribose) polymerase family member 11/Poly [ADP-ribose] polymerase 11 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2380189] [GtoPdb: 3268] [UniProtKB: Q9NR21] | ||||||||
| ChEMBL | Inhibition of full length human His-SUMO-tagged PARP11 expressed in Escherichia coli BL21 assessed as reduction in MARylation of His6-tagged SRPK2 substrate after 60 mins in presence of NAD+ by chemifluorescence assay | B | 5.68 | pIC50 | 2100 | nM | IC50 | ACS Med Chem Lett (2019) 10: 74-79 [PMID:30655950] |
| ChEMBL | Inhibition of full length human His-SUMO-tagged PARP11 expressed in Escherichia coli BL21 assessed as reduction in MARylation of His6-tagged SRPK2 substrate after 60 mins in presence of NAD+ by chemifluorescence assay | B | 5.68 | pIC50 | 2089.3 | nM | IC50 | ACS Med Chem Lett (2019) 10: 74-79 [PMID:30655950] |
| Poly [ADP-ribose] polymerase 12 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2429709] [UniProtKB: Q9H0J9] | ||||||||
| ChEMBL | Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD12 (469 to 701 residues) expressed in Escherichia coli Rosetta2 (DE3) after 20 hrs in presence of NAD+ | B | 5 | pIC50 | >10000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| poly(ADP-ribose) polymerase family member 14/Poly [ADP-ribose] polymerase 14 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2176777] [GtoPdb: 3269] [UniProtKB: Q460N5] | ||||||||
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP14 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 4.63 | pIC50 | 23400 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD8 (1535 to 1801 residues) expressed in Escherichia coli Rosetta2 (DE3) after 21 hrs in presence of NAD+ | B | 4.64 | pIC50 | 23000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| ChEMBL | Inhibition of full length recombinant His6-tagged human PARP14 WWA/catalytic domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5 | pIC50 | 10000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of full length recombinant His6-tagged human PARP14 WWA/catalytic domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay | B | 5 | pIC50 | 10000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| poly(ADP-ribose) polymerase family member 15/Poly [ADP-ribose] polymerase 15 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2176778] [GtoPdb: 3270] [UniProtKB: Q460N3] | ||||||||
| ChEMBL | Inhibition of N-terminal His-tagged human ARTD7 (482 to 678 residues) expressed in Escherichia coli Rosetta2 (DE3) using SRPK2 as substrate after 3 hrs in presence of NAD+ | B | 5 | pIC50 | >10000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP15 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 5.38 | pIC50 | 4170 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| poly(ADP-ribose) polymerase 2/Poly [ADP-ribose] polymerase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5366] [GtoPdb: 2772] [UniProtKB: Q9UGN5] | ||||||||
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP2 catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD2 (1 to 583 residues) expressed in Escherichia coli Rosetta2 (DE3) using activated DNA as substrate after 1.5 hrs in presence of NAD+ | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| poly (ADP-ribose) polymerase 3/Poly [ADP-ribose] polymerase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5083] [GtoPdb: 2864] [UniProtKB: Q9Y6F1] | ||||||||
| ChEMBL | Inhibition of N-terminal His-tagged thioredoxin-fused human ARTD3 (1 to 533 residues) expressed in Escherichia coli Rosetta2 (DE3) using DNA as substrate after 3 hrs in presence of NAD+ | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| Poly [ADP-ribose] polymerase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6142] [UniProtKB: Q9UKK3] | ||||||||
| ChEMBL | Inhibition of N-terminal His-tagged human ARTD4 (250 to 565 residues) expressed in Escherichia coli Rosetta2 (DE3) using TCEP as substrate after 2.5 hrs in presence of NAD+ | B | 4.64 | pIC50 | 23000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| tankyrase/Tankyrase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6164] [GtoPdb: 3108] [UniProtKB: O95271] | ||||||||
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP5A catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of N-terminal His-tagged human ARTD5 (1030 to 1317 residues) expressed in Escherichia coli Rosetta2 (DE3) using TCEP as substrate after 18 hrs in presence of NAD+ | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
| tankyrase 2/Tankyrase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6154] [GtoPdb: 3109] [UniProtKB: Q9H2K2] | ||||||||
| ChEMBL | Inhibition of full length recombinant His6-tagged PARP5B catalytic domain (unknown origin) expressed in Escherichia coli BL21(DE3) by fluorescence based assay | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 2050-2054 [PMID:29748053] |
| ChEMBL | Inhibition of N-terminal His-tagged Z-basic-fused human ARTD6 (873 to 1161 residues) expressed in Escherichia coli Rosetta2 (DE3) using TCEP as substrate after 18 hrs in presence of NAD+ | B | 4 | pIC50 | >100000 | nM | IC50 | Eur J Med Chem (2018) 156: 93-102 [PMID:30006177] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
